Influence of patient-related variables on clozapine plasma levels
- 1 November 1990
- journal article
- research article
- Published by American Psychiatric Association Publishing in American Journal of Psychiatry
- Vol. 147 (11), 1471-1475
- https://doi.org/10.1176/ajp.147.11.1471
Abstract
The authors investigated the clozapine plasma levels of 148 psychiatric inpatients. Multiple regression analysis revealed a linear relationship between dose of clozapine and plasma concentrations. The analysis showed a signficant influence of dose, sex, smoking, weight, and age on the plasma concentrations of clozapine under clinical conditions. These results remained significant when clozapine doses below 150 mg/day and above 500 mg/day were excluded from the analysis.This publication has 9 references indexed in Scilit:
- Clozapine for the Treatment-Resistant SchizophrenicArchives of General Psychiatry, 1988
- Clozapine plasma levels determined by high-performance liquid chromatography with ultraviolet detectionJournal of Chromatography B: Biomedical Sciences and Applications, 1988
- Commentary: The Strategy and Value of Neuroleptic Drug MonitoringJournal of Clinical Psychopharmacology, 1985
- Clozapine: Plasma levels and prolactin responsePsychopharmacology, 1981
- Effects of age and cigarette smoking on propranolol dispositionClinical Pharmacology & Therapeutics, 1979
- Clinical Pharmacokinetics of HypnoticsClinical Pharmacokinetics, 1977
- Serum concentrations of clozapine determined by nitrogen selective gas chromatographyArchives of Toxicology, 1977
- Effect of smoking on theophylline dispositionClinical Pharmacology & Therapeutics, 1976
- Effect of cigarette smoking on phenacetin metabolismClinical Pharmacology & Therapeutics, 1974